Top compounds associated with response to DYTN


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA etomoxir CTRPv2 pan-cancer AAC 0.052 0.2
mRNA GDC-0449 GDSC1000 pan-cancer AAC -0.05 0.2
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.05 0.2
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.045 0.2
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.048 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.064 0.2
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.049 0.2
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.048 0.2
Download CSV